Baird Initiates Coverage On Inspire Medical Systems with Outperform Rating, Announces Price Target of $371
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Mike Polark has initiated coverage on Inspire Medical Systems (NYSE:INSP) with an Outperform rating and a price target of $371.
July 19, 2023 | 8:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems has received an Outperform rating from Baird with a price target of $371.
The Outperform rating from Baird indicates a positive outlook for Inspire Medical Systems. The price target of $371 suggests a significant upside potential from the current price. This could lead to increased investor interest and a potential increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100